Individualized dynamic risk assessment and treatment selection for multiple myeloma.

Journal: British journal of cancer
Published Date: Apr 1, 2025

Abstract

BACKGROUND: Individualized treatment decisions for multiple myeloma (MM) patients require accurate risk stratification that accounts for patient-specific consequences of cytogenetic abnormalities on disease progression.

Authors

  • Carl Murie
    Institute for Systems Biology, Seattle, WA, USA.
  • Serdar Turkarslan
    Institute for Systems Biology, Seattle, WA, USA.
  • Anoop P Patel
    Department of Neurosurgery, Duke University, Durham, NC, USA.
  • David G Coffey
    Division of Myeloma, University of Miami, Miami, FL, USA.
  • Pamela S Becker
    Center for Cancer Innovation, University of Washington, 850 Republican Street, Seattle, WA, 98109, USA.
  • Nitin S Baliga
    Institute for Systems Biology, Seattle, WA, USA. nitin.baliga@isbscience.org.

Keywords

External Resources

Popular Topics
Recent Journals